CancerDrs

Thyroid Cancer clinical trials in Oklahoma

1 actively recruiting thyroid cancer trials at 2 sites across Oklahoma.

Data from ClinicalTrials.gov · last refreshed

Phase 3 Recruiting Network

Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer

This phase III trial compares the effect of cabozantinib versus combination dabrafenib and trametinib for the treatment of patients with differentiated thyroid cancer that does not respond to treatment (refractory) and which expresses a BR…

Sponsor: ECOG-ACRIN Cancer Research Group
NCT ID: NCT06475989
Sites in Oklahoma:
  • Cancer Centers of Southwest Oklahoma Research — Lawton, Oklahoma
  • University of Oklahoma Health Sciences Center — Oklahoma City, Oklahoma
  • Mercy Hospital Oklahoma City — Oklahoma City, Oklahoma
View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-11-09